← Back to Clinical Trials
Recruiting NCT06357845

Linking Somatic Mutation Rate With Baseline Exposure in East Palestine

Trial Parameters

Condition Somatic Mutation
Sponsor Case Comprehensive Cancer Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-16
Completion 2026-09-30
Interventions
SurveyBiological specimen collectionCommunications about study updates and future research opportunities

Brief Summary

The goal of this study is to This research team is conducting this study to develop methods to measure the biological impact of exposure to the chemicals released following the February 3, 2023 train derailment on residents of East Palestine, Ohio, and surrounding communities. The main question it aims to answer is: * What biological impact will be measured based on DNA damage? * In participants who provide a biospecimen, how are biomarker changes related to proximity to the derailment and variations in residents' health histories and behaviors? Participants will: * Complete a brief survey asking about experiences related to the February 3, 2023 train derailment, health experiences, and concerns following the derailment, and background information regarding health history. * Possibly contribute biospecimens such as blood, spit, hair, and/or toenail clippings. * Receive communication about study updates and future research opportunities. * A total of 40 study participants will be recruited to participate in a 90-minute interview. The interviews will be video and audio recorded.

Eligibility Criteria

Inclusion Criteria: * Residence on February 3rd, 2023 in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA. * Current residence in the United States. Exclusion Criteria: * Address provided for February 3rd, 2023 not in Columbiana County, Ohio, Mahoning County, Ohio, Beaver County, PA, or Lawrence County, PA * Invalid address provided for February 3rd, 2023 residence.

Related Trials